Dr. Antonio Fojo Joins Imaging Endpoints' Scientific Advisory Board
Retrieved on:
Wednesday, September 7, 2022
Columbia University, National Cancer Institute, Technology, Research, Columbia University Irving Medical Center, Artificial intelligence, Doctor of Philosophy, IE, United States Air Force Scientific Advisory Board, CD8, Cure, ESMO, Principal, Multimedia, MBA, Medicine, TGK, SMIL, Progression-free survival, Cancer, Drug resistance, Daniel Von Hoff, Thyroid cancer, Ovarian cancer, National, Patient, Squamous cell carcinoma, Pharmaceutical industry, Medical imaging
SCOTTSDALE, Ariz., Sept. 7, 2022 /PRNewswire/ -- Imaging Endpoints (IE) announced today that Dr. Antonio Fojo was chosen to join their Scientific Advisory Board, a global group of leading medical professionals appointed to provide strategic insight and imaging-related expertise for optimizing the opportunity to demonstrate efficacy in clinical trials.
Key Points:
- SCOTTSDALE, Ariz., Sept. 7, 2022 /PRNewswire/ -- Imaging Endpoints (IE) announced today that Dr. Antonio Fojo was chosen to join their Scientific Advisory Board, a global group of leading medical professionals appointed to provide strategic insight and imaging-related expertise for optimizing the opportunity to demonstrate efficacy in clinical trials.
- The Scientific Advisory Board leverages their expertise to advise Imaging Endpoints on the imaging design for global clinical trials wherein IE is providing its Imaging CRO services.
- For more information on the Imaging Endpoints Scientific Advisory Board, visit https://imagingendpoints.com/meet-our-team/scientific-advisory-board/
IE team will be in Paris for ESMO 2022! - Imaging Endpoints is headquartered in Scottsdale, AZ, with offices in Cambridge, MA; London, UK; Leiden, Netherlands; Basel, Switzerland; Hyderabad, India and Shanghai, China.